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Normal enteric nervous system (ENS) development relies on numerous factors, including appropriate
migration, proliferation, differentiation, and maturation of neural crest (NC) derivatives. Incomplete
rostral to caudal migration of enteric neural crest-derived progenitors (ENPs) down the gut is at least
partially responsible for the absence of enteric ganglia that is a hallmark feature of Hirschsprung
disease (HSCR). The thought that ganglia proximal to aganglionosis are normal has guided surgical
procedures for HSCR patients. However, chronic gastrointestinal dysfunction suffered by a subset of
patients after surgery as well as studies in HSCR mouse models suggest that aberrant NC segregation
and differentiation may be occurring in ganglionated regions of the intestine. Studies in mouse models
that possess enteric ganglia throughout the length of the intestine (non-HSCR) have also found that
certain genetic alterations affect neural crest lineage balance and interestingly many of these mutants
also have functional gastrointestinal (GI) defects. It is possible that many GI disorders can be explained
in part by imbalances in NC-derived lineages. Here we review studies evaluating ENS defects in HSCR
and non-HSCR mouse models, concluding with clinical implications while highlighting areas requiring
further study.
& 2013 Elsevier Inc. All rights reserved.Introduction
The enteric nervous system (ENS) is a complex network of
ganglia intrinsic to the intestinal wall that is necessary for normal
motility and homeostasis of the gastrointestinal (GI) tract. The
ENS originates from vagal, rostral truncal, and sacral neural crest
(NC) populations that migrate to the fetal gut in the developing
embryo (Burns, 2005). In the mouse, vagal and rostral trunk
neural crest cells (NCC) emigrate from the neural tube to the
foregut and migrate caudally to populate the entire gut. Sacral
NCC delaminate later from the neural tube, enter the hindgut, and
migrate rostrally, opposite the vagal NCC, to co-populate the post-
umbilical portion of the gut. As these populations migrate from
the neural tube and along the gut, cell-autonomous signaling as
well as cues from the environment play a role in their lineage
divergence (Burns, 2005). NCC contributing to the ENS, appro-
priately called enteric neural progenitors (ENPs), differentiatell rights reserved.
epartment of Medicine,
ll, Nashville, TN 37232-0275,
bilt.edufrom a stem cell-like state to give rise to glia and numerous
neuronal types (Heanue and Pachnis, 2011; Pham et al., 1991;
Sang and Young, 1996). For successful ENS development, correct
timing and dosage of gene expression affecting ENP survival,
proliferation, and differentiation is essential. The necessity of
balancing these processes is clearly seen in the human functional
bowel disorder, Hirschsprung disease (HSCR), which is clinically
recognized by the absence of ganglia in a variable portion of the
distal intestine.
Research in ENS development has previously focused on HSCR
in part because of the dramatic megacolon phenotype that results
from aganglionosis of the distal bowel. This spotlight has
remained trained on HSCR as a GI disorder due to success in
identifying susceptibility genes in patients and the recapitulation
of aganglionosis in rodent models bearing mutations in homo-
logous genes (Chakravarti et al., 2006). Concurrent advances in
treating HSCR patients through surgical removal of distal agan-
glionic bowel followed by reattachment of ganglionated proximal
intestine to the anus has led to increased survival (Amiel et al.,
2008). Yet long term clinical follow-up of HSCR patients has found
that surgical intervention does not completely ‘‘cure’’ intestinal
symptoms in these individuals who continue to suffer from
intestinal disorders, such as enterocolitis and chronic constipation,
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(Amiel et al., 2008; Austin, 2012; Chumpitazi and Nurko, 2011; Kaul
et al., 2011). The occurrence of such chronic bowel dysfunction
across a variety of surgical procedures (Chumpitazi and Nurko,
2011) and evidence from developmental studies of HSCR mouse
models (Paratore et al., 2001, 2002; Walters et al., 2010) hint that
defects in ENS development in the proximal, ganglionated portions
of the intestine may be causative. In particular, mechanistic
analyses of HSCR mouse models indicate that defects in ENP
developmental potential, the ability of NCC to differentiate into a
variety of cell types, contribute to HSCR. Moreover, the concept that
imbalance of NC-derived cell types within the ENS could lead to GI
dysfunction is gaining strength, fueled by evidence from gene-
speciﬁc mouse mutants that lack aganglionosis yet show deﬁcits in
ENS lineages, GI motility and immune response (see Table 1). This
review collates multiple studies whose evidence adds weight to this
concept and raises future questions for the ﬁeld to address.Evidence from HSCR mouse models
Early studies in HSCR mouse models focused on determining
the genetic causes of aganglionosis in spontaneously occurring
mutants as a means to identify genes that contribute to develop-
ment of the ENS. Initially, little thought was given to the
possibility that ENS defects in ganglionated regions of the bowel
might contribute to intestinal dysfunction. However, more
recently, abnormalities in proximal ganglionated regions of the
intestine have been recognized (Cantrell et al., 2004; Jain et al.,
2004; Walters et al., 2010). This discovery led investigators to
hypothesize that long term complications in HSCR patients could
result from deﬁciencies in ganglia that had been formed in the
proximal intestine (Jain et al., 2004; Walters et al., 2010). As the
ﬁeld has learned more about the developmental processes that
contribute to aganglionosis in mouse models, evidence for effects
of individual HSCR genes on NCC lineage divergence in the fetal
intestine has emerged.Sox10
Mice with a loss-of-function Sox10þ / (Sox10Lacz or Sox10tm1Weg)
(Paratore et al., 2001, 2002) or a dominant-negative allele of Sox10
(Sox10Dom/þ) (Kapur, 1999; Southard-Smith et al., 1998) both recapi-
tulate the HSCR phenotype of distal bowel aganglionosis. The ﬁrst
hint that perturbations in normal Sox10 levels could produce altera-
tions in development potential came from in vitro studies conducted
on neural crest-derived progenitors isolated from dorsal root ganglia
of Sox10 / , Sox10þ / , and Sox10þ /þ embryos (Paratore et al., 2001).
These isolated cells were allowed to grow and then differentiate in
culture. The developmental potential of isolated progenitors was
scored by the differentiated cell types these cultured cells produced.
Sox10 deﬁcient NCC showed altered developmental potential and
were deﬁcient in gliogenesis at both high and low plating densities.
While this study focused on neural crest-derived cells collected from
dorsal root ganglia, a subsequent effort by the same group deter-
mined that the temporal appearance of early and late neuronal
differentiation markers within the fetal foregut and midgut of
Sox10þ / mutants in vivo were also disrupted (Paratore et al.,
2002). Careful analysis revealed that neural progenitor cells expres-
sing early neuronal markers like PGP9.5 were increased in frequency
among Sox10þ / mutants, while more mature neurons marked by
expression of neuroﬁlament 160 were reduced. Interestingly,
although the NC progenitor pool was decreased in Sox10þ / mutants,
total neuronal numbers were not, suggesting that reduction of Sox10
promotes a neural fate, but may not contribute to later neuraldifferentiation processes. Whether these fetal irregularities persist in
the postnatal intestine of Sox10þ / mutants remains in question.
An independent study assessed developmental potential of
ENPs for the dominant-negative allele of Sox10, Sox10Dom/þ , while
concurrently investigating the effects of genetic strain back-
ground on ENS development (Walters et al., 2010). This analysis
found that ENPs from Sox10Dom/þ mutants also had altered
developmental potential in vivo and documented ENS irregula-
rities in fetal and postnatal intestine of heterozygous Sox10Dom/þ
mice. Moreover, the authors reported atypical myoﬁbroblast-like
cells with cytoplasmic Phox2b expression in and around myen-
teric ganglia. While similar cells were also observed in wild-type
littermates, the overall number of these unusual cells was
increased in Sox10Dom/þ mutants. Taken together the studies by
Paratore et al. (2001, 2002), and Walters et al. (2010), suggest that
altered developmental potential of NCC, including enteric cell
types, occurs in HSCR individuals carrying disruptions of Sox10.
It remains to be determined whether this altered developmental
potential ultimately disrupts the balance of cell types in the
postnatal enteric ganglia and how such alterations would affect
intestinal function.
Ednrb/Edn3
Endothelin receptor B (Ednrb) is expressed in migrating NCC
while its preferred ligand, Endothelin 3 (Edn3) is expressed in the
gut wall. Several spontaneously occurring and genetically modiﬁed
rodent models with altered Ednrb or Edn3 expression exist
(Baynash et al., 1994; Druckenbrod et al., 2008; Hosoda et al.,
1994; Roberts et al., 2008; Rothman and Gershon, 1984). However
only a single study has documented alterations in proximal ENS
density and patterning among Ednrbs-l/s-l homozygous mutants
(Cantrell et al., 2004). While no analysis of cell types in postnatal
intestine of these or other Ednrb mutants has been published to
date, Ednrb mutants do exhibit enterocolitis that leads to early
death. Fujimoto et al., (1988a) ﬁrst described the presence of
enterocolitis in the piebald lethal (Ednrbs-l/s-l) mouse. Ednrbs-l/s-l
mice have an increase in enterocolitis compared to wild-type
littermates and a subset of Ednrbs-l/s-l mice die presumably due to
acute infectious processes as they have no gross megacolon, but
exhibit acute splenitis and an increase in intestinal Ig-A secreting
plasma cells at time of death (Fujimoto et al., 1988b). Similarly, a
subset of Ednrb-null (EdnrbTm1Ywa/Tm1Ywa, hereafter referred to as
Ednrb /) mice die prematurely with signs of widespread bacter-
emia (Cheng et al., 2010). Interestingly, these inﬂammatory pro-
cesses appear mediated, at least in part, by ganglionated portions
of the intestine as 40% of Ednrb / mice that undergo corrective
pull-through surgery to remove aganglionic bowel still go on to
develop enterocolitis (Zhao et al., 2010). Mice with mutations in
Edn3 (Et-3) have not been assessed for enterocolitis, but have been
evaluated for altered GI motility and proportions of enteric
neurons. ET-3  / (Edn3tm1Ywa/tm1Ywa) lack colonic migrating motor
complexes in the ganglionated portions of their bowel. Addition-
ally, despite having a lower density of neurons in the myenteric
plexus, they have twice as many NOS expressing neurons com-
pared to their wild-type littermates (Roberts et al., 2008).
Ret signaling pathway
Gene deﬁcits among members of the Ret signaling pathway
have been the most extensively studied models for HSCR pheno-
types. Ret is a receptor tyrosine kinase expressed on ENPs that has
documented roles in proliferation, migration, and survival of
these cells. Although several Ret ligands and co-receptors exist,
Ret signaling in the development of the ENS primarily occurs in
Table 1
Summary of mutant allele effects on enteric nervous system structure and function. Changes in ENS architecture and density apply to ganglionated regions of the bowel for
HSCR mouse models. Fields marked as ‘‘unknown‘‘ indicate data not reported, or mouse model not tested.
Allele ENS density ENS architecture NCC lineage balance Effect on GI function Inﬂammatory
response
References
Sox10Dom/þ Decrease in
ENPs
Variable
disorganized
patterning
observed
In vitro data Unknown Unknown Kapur, (1999),
Southard-Smith et al., (1998),
Walters et al., (2010)
Sox10LacZ/þ Decrease in
ENPs
Postnatal
unknown
In vitro data; increase in
immature neuronal markers
in vivo
Unknown Unknown Paratore et al., (2002) Paratore
et al., (2001)
Ednrbs-l/s-l Decreased
intensity of
AChE ﬁbers
Abnormal
patterning
Unknown Unknown Unknown Cantrell et al., (2004))
EdnrBs-l/s-l or
EdnrBsl/þ
Decreased
through
colon
Unknown Unknown Absent or impaired colonic
migrating motor complexes
Subset
susceptible to
enterocolitis
Cantrell et al., (2004), Fujimoto,
(1988a), Fujimoto et al., (1988b),
Hosoda et al., (1994)
Ednrbtm1Ywa/þ
or
Ednrbtm1Ywa/
tm1Ywa
Unknown Unknown Unknown Unknown Subset
susceptible to
enterocolitis
Cheng et al., (2010), Hosoda
et al., (1994), Zhao et al., (2010)
ET-3 / Decreased
neuronal
numbers
Unknown Increased NOSþ neurons Absent colonic migrating
motor complexes
Unknown Roberts et al., (2008)
Rettm1Cos/þ Normal
neuronal
numbers
Decreased neuron
size and
cholinergic ﬁbers
Unknown Reduced contractility; but
ENS signaling aberrant
Unknown Gianino et al., (2003)
Ret DN/þ Decreased
neuronal
numbers
Decreased
neuronal ﬁber
density
Unknown Unknown Unknown Jain et al., (2004)
RetC620R/þ Decreased
neuronal
numbers
Decreased
neuronal ﬁber
density
Unknown Unknown Unknown Carniti et al., (2006)
Gfraþ / Normal
neuronal
numbers
Decreased neuron
size
Unknown Reduced contractility; ENS
signaling aberrant; delayed
GI transit
Unknown Gianino et al., (2003)
Wang et al., (2010)
Gdnf þ / Decreased
neuronal
numbers
Alterations
observed, but not
signiﬁcant
Reduction in NOSþ and
CHATþ neurons, but
proportional to overall
neuronal decreases
Reduced contractility; ENS
signaling aberrant
Unknown (Gianino et al., (2003), Shen
et al., (2002); Wang et al., (2010)
Gdnf over
expression
Neuronal
numbers
increased
Changes in ﬁber
density with
increased Gdnf
expression
Increases in late born neuron
subtypes
Stronger contractility;
increased VIP and
Substance P release;
accelerated GI transit
Unknown Wang et al., (2010)
Ascl1 /
(Mash1 /)
Decreased
neuronal
numbers
Wide spacing,
erratic
arrangement of
ganglia
CGRPþ neuronal
numbers normal,
other subtypes unknown
Unknown Unknown Blaugrund et al., (1996)
TPH2  / Decreased
neuronal
density in
ileum
Unknown Decreased dopaminergic
neurons
Slowed total GI transit and
colonic emptying;
accelerated gastric
emptying
Unknown Li et al., (2011)
D2
 / Unknown Unknown Unknown Faster total GI transit and
colonic emptying;
absorption affected
Unknown Li et al., (2006)
Hand2 (Nestin-
del)
Decreased
neuronal
numbers
Disorganized plexi Decreased CHATþ , NOSþ ,
and calretininþ neurons and
glia
Unknown Unknown Lei and Howard, (2011)
Hand2þ / or
Hand2ﬂox/
Decreased
neuronal
numbers
Disorganized plexi Signiﬁcant decrease in NOSþ
neurons
Decreased GI motility Decreased
susceptibility to
induced
inﬂammation
D’Autreaux et al., (2011)
BMP over
expression
No changes in
neuronal
density
Unknown Region speciﬁc increases in
dopaminergic, 5-HTþ and
TrkCþ neurons; glia
increased
Unknown Unknown Chalazonitis et al., (2004),
Chalazonitis et al., (2011),
Chalazonitis et al., (2008)
Noggin over
expression
Increased
neuronal
numbers
Increased density Increased TrkCþ , 5-HTþ
neurons, decreased GABAþ
and CGRPþ neurons
Irregular transit; increased
stool frequency, weight and
water content
Increased
susceptibility to
induced
inﬂammation
Chalazonitis et al., (2004),
Chalazonitis et al., (2011),
Chalazonitis et al., (2008),
Margolis et al., (2011)
Fgf-2 / Decreased
neuronal
numbers
Changes in neurite
length; larger
neurons
Decreased calbindinþ
neurons
Reduced chloride-ion
secretion; mucosal barrier
defects
Unknown Hagl et al., (2008),
Hagl et al., (2012)
NET / Decrease in
myenteric
neuronal
numbers
Unknown 5-HTþ and calretininþ
neurons reduced
Unknown Unknown Li et al., (2010)
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Gdnf (Gianino et al., 2003).
In humans, a single functional mutation in RET is sufﬁcient to
cause HSCR. In mice, gene targeting of Ret (Rettm1Cos/tm1Cos,
commonly referred to as Ret /) results in complete loss of the
ENS in the small and large intestines (Schuchardt et al., 1994,
1995). However, mice with heterozygous loss (Retþ /) appear
normal and healthy, with no aganglionosis or loss of neuron
numbers in either myenteric or submucosal ganglia (Gianino
et al., 2003). Whether the proportions of various neuron subtypes
in Retþ /þ and Retþ / are equivalent remains unknown. Interest-
ingly, Retþ / mice do show a reduction in neuron size and
cholinergic neuronal ﬁber count in certain regions of the bowel
and also exhibit deﬁcits of intestinal contractility (Gianino et al.,
2003). The cellular basis of the motility deﬁcits observed in
heterozygous Retþ / mutants is of interest not only from a
mechanistic standpoint, but also because heterozygous deﬁcien-
cies are more prevalent in patient populations.
Intermediate phenotypes in Ret mutant mice that exhibit the
distal aganglionosis present in human HSCR patients have been
produced. These include the RetDN/þ (Rettm3.1Jmi/þ) mouse that
harbors a dominant-negative mutation (Jain et al., 2004) and the
RetC620R/þ (Rettm1Cti/þ) mouse that carries a gain-of-function point
mutation (Carniti et al., 2006). NC lineage segregation, processes that
generate normal proportions of neurons and glia or neuronal sub-
types in development, has not been evaluated in either of these two
models. However, the ENS in the proximal bowel of the RetDN/þ
mouse contains fewer neurons and exhibits decreased neuronal ﬁber
density. These heterozygous models provide an ideal opportunity to
investigate roles for Ret in NC lineage segregation.
Gfra1 (Gdnf receptor alpha-1) is a GPI-linked co-receptor that
preferentially binds Gdnf (glial derived neurotrophic factor) with
Ret (Jing et al., 1996; Treanor et al., 1996). Deﬁcits in ENS
development in Gfra1 mutants tend to recapitulate those found
in Ret mutants. This evidence supports the theory that Ret
signaling through Gfra1 and Gdnf, not other co-receptor:ligand
pairs, is largely acting in early ENS development. Similar to
complete loss of Ret, ablation of Gfra1 (Gfratm3Jmi/tm3Jmi, commonly
called Gfra /) leads to a nearly complete absence of neurons in
the small intestine and colon (Cacalano et al., 1998; Enomoto
et al., 1998). And, as is seen for Ret heterozygous mutants, animals
lacking a single copy of Gfra1 possess normal numbers of neurons
in both myenteric and submucosal plexi, but signiﬁcant reduc-
tions in neuron cell size are evident in some regions of the
intestine and contractility of the intestine is abnormal in these
animals (Gianino et al., 2003).
Studies from mouse models with altered Gdnf expression,
particularly those that disrupt levels or timing of Gdnf produc-
tion, provide the best evidence to date that Ret signaling inﬂu-
ences ENP lineage divergence. Similar to Ret and Gfra1 knockouts,
Gdnf null mice (Gdnf tm1Rosl/tm1Rosl knockout mutants, commonly
called Gdnf /) do not develop enteric ganglia caudal to the
stomach and exhibit early lethality. However Gdnfþ / mice, in
contrast to Retþ / and Gfra-1þ / mutants, do exhibit hypogan-
glionosis throughout the intestine (Shen et al., 2002). To investi-
gate the effect of Gdnf expression levels on ENS development,
Wang et al. (2010) over-expressed Gdnf in the fetal intestine.
Overexpression initiating at embryonic day 17 was accomplished
using transgene constructs that conferred expression in enteric
glia or the muscle cells, while postnatal, global Gdnf expression
was accomplished through daily peritoneal injections starting at
birth. Both modes of Gdnf overexpression resulted in increased
neuronal proliferation in submucosal neurons of the small intes-
tine as well as neurons of both plexi in the colon. While myenteric
neurons in the small intestine showed no signiﬁcant increases in
proliferation, the timing of GDNF overexpression affectedsubmucosal neuronal subtypes. Early born neuron subtypes that
were established before the onset of GDNF overexpression, such
as serotonergic neurons, and ChAT expressing neurons, were not
signiﬁcantly affected. However, neurons that appear early but
also continue to be born in the postnatal period, such as NOSþ
neurons, were signiﬁcantly increased in number in both Gdnf
overexpression models. In addition, gross intestinal contractility
changes were found in mice with Gfap-driven Gdnf overexpres-
sion. While the altered contractility may indirectly correlate with
increased numbers of NOS neurons, the mechanistic basis
remains to be determined as electrical properties of speciﬁc
neuronal subtypes were not evaluated and multiple neuronal
subtypes were not examined. It will be interesting to determine if
overexpression of Gdnf before embryonic day 17 alters ratios and
functionality of earlier born neuronal subtypes or if postnatal
reduction of Gdnf levels cause reductions in late born
neuron types.
It is worth noting that while Ret signaling through the
Gfra1:Gdnf (co-receptor:ligand) combination plays an early and
major role in ENS development, signaling through interactions
with Gfra2:Nrtn plays a later role. This is especially relevant for
the maintenance and proliferation of neurons in the submucosal
plexus of the small intestine and both plexi of the colon (Gianino
et al., 2003). The possibility that Gfra2:Nrtn are able to compen-
sate for a loss of Gdnf in late stages of development expression or
whether this axis selectively affects NC subtypes is yet to be
determined. While heterozygous Retþ / , Gfra-1þ / , and Gdnf þ /
mouse mutants do not exhibit the absence of enteric ganglia in
the distal intestine that is characteristic of HSCR, all of these
models share loss of intestinal contractility and exhibit reduced
release of neurotransmitters in vitro (Gianino et al., 2003). Under-
standing the causes of altered GI motility is crucial for developing
strategies to treat patients with functional GI deﬁcits that com-
prise a substantial proportion of the population. The realization
that heterozygous deﬁciency of Ret, Gfra1, and Gdnf alters the
composition and functionality of the ENS likely would not have
come about without efforts to better understand the rare disorder
HSCR. These results nicely illustrate how studies of rare disorders
can inform common problems.Evidence from non-HSCR models
Although mouse mutants have been used to model the obvious
aganglionosis that occurs in human HSCR, studies in non-HSCR
mouse models provide the most substantial evidence that dis-
ruption of NC-derived lineages can occur in the ENS and that
these imbalances can alter GI function. Understanding the etiol-
ogy of GI dysmotility is relevant to a large fraction of the
population as millions of people suffer from intestinal motility
disorders. Surprisingly, the etiologies of chronic constipation,
pseudo-obstruction, Crohn’s disease, ulcerative colitis, and other
GI disorders that appear to have genetic components remain
relatively obscure (Karban et al., 2004; Ostwani et al., 2010; Van
Limbergen et al., 2009; Villani et al., 2010). Given the evidence
detailed below, it is likely that ENS defects, including abnormal
NC lineage segregation, contribute signiﬁcantly to many GI dis-
orders. Discoveries in non-HSCR mouse models should aid in
teasing apart the etiologies of these disorders.
Ascl1 (formerly Mash-1)
Ascl1 (Mash-1) is a basic helix–loop–helix transcription factor
most extensively studied for its role in neurogenesis in the central
and sympathetic nervous systems (Bertrand et al., 2002). How-
ever, Ascl1 also largely inﬂuences development in a subpopulation
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enteric progenitors give rise to a subset of transiently catechola-
minergic cells which differentiate into serotonergic neurons.
Transiently catecholaminergic cells initially express catecholami-
nergic gene products, such as tyrosine hydroxylase, but lose
catecholominergic gene expression upon differentiation. Ascl1
null embryos (Ascl1tm1And/tm1And, commonly referred to as
Ascl1 /) have severely reduced neuronal serotonin (5-HT)
expression and exhibit gross ENS deﬁcits, such as a reduction in
overall neuronal number and more widely spaced and erratically
arranged ganglia. This study only evaluated one other neuronal
subtype, the late born CGRP (calcitonin gene related peptide)
expressing neurons, which appeared unaffected in Ascl1 null
mutants. Recent studies described below have found that pertur-
bations in neuronal serotonin expression alter neuronal subtype
proportions and development, thus it would be interesting to
evaluate other neuronal subtypes in the Ascl1/ mutants.
Serotonin (5-HT)
Although serotonergic neurons only comprise 1–2% of the myen-
teric plexus in rodents (Furness, 2006), they are one of the earliest
types of neurons that exit the cell cycle in the developing ENS (Pham
et al., 1991) and they also affect the development of later born
neurons, GI motility (Li et al., 2011), and GI epithelial growth (Gross
et al., 2012). The exact role 5-HT plays in GI development and
function has been somewhat obscured by the fact that two 5-HT
expressing cell types exist in the gut— enterochromafﬁn cells within
the gut epithelium and neurons within the myenteric and submuco-
sal plexi. The recent, fortuitous discovery that 5-HT expressing
epithelial cells rely on the enzyme Tph1 (tryptophan hydroxylase 1)
for 5-HT synthesis while enteric neurons rely on the enzyme Tph2
(tryptophan hydroxylase 2) (Gershon and Tack, 2007; Neal et al.,
2009) has permitted a more thorough investigation of 5-HT in ENS
development. Li et al. (2011) conducted a study utilizing Tph1, Tph2,
and Tph1/2 knockout (KO) mice to determine the effects of 5-HT
depletion (epithelial vs neuronal vs total gut respectively) on enteric
development and GI motility. These studies identiﬁed perturbations
of both ENS development and GI motility in the Tph2 KO (neuronalFig. 1. Schematic diagram illustrating potential mechanisms by which alterations in gen
myenteric ganglia is shown consisting of multiple neuronal subtypes (ChATþ green, 5-H
along inter-ganglia ﬁbers, and within the underlying muscle (gray ovals/stellate cell s
subtypes (such as the decrease in CHATþ neurons seen in the inset, fewer green ne
alterations — as well as more subtle changes — could disrupt the electrical properties
other cell types like those of the immune system. Such changes could ultimately result5-HT depleted) mice. In contrast such perturbations were not seen in
Tph1 single knockout or exacerbated in the Tph1/2 double knockouts.
In comparison to wild-type ENS development, Tph2 KO mice had a
signiﬁcantly lower neuronal density in the ileum and a signiﬁcant
decrease in the late born dopaminergic neurons. Complementary
gain-of-function experiments using ENPs isolated from Slc6a /
(serotonin transporter) mutants, as well as treatment of ENP cultures
with 5-HT both conﬁrmed and extended the ﬁnding that 5-HT
impacts development of dopaminergic neurons in the fetal intestine.
Functional deﬁcits due to loss of neuronal 5-HT were also documen-
ted in Tph2 KO mice including signiﬁcantly faster gastric emptying
but overall slower total GI transit and colonic emptying. A schematic
illustrating how disruption of one enteric neuronal population, like
5-HTþ neurons, might impact cell types within the ganglia is
diagrammed in Fig. 1. Experiments to investigate the effect of
neuronal 5-HT overexpression on ENS development and GI motility
have yet to be conducted.
Dopamine receptor 2 (Drd2)
Do alterations of ENS dopaminergic signaling signiﬁcantly alter
GI function? Li et al. (2006) conducted a study in which dopami-
nergic signaling was disrupted through dopamine (Drd2) receptor
knockouts. Five dopaminergic receptors (Drd1a-5) are expressed in
the gut, but Drd2 is restricted to enteric neurons. Drd2 / (allele
name Drd2tm1Schm/tm1Schm) knockout mice had faster total GI transit
times as well as faster colonic motility when compared to wild-
type littermates. Absorption of food was affected as Drd2
 / mice
were runted although they ate more food and drank more water
than wild-type siblings. Other neurons and other cell types receiv-
ing signals from dopaminergic neurons in the bowel may be able to
compensate for changes in dopaminergic neuron number or func-
tion by altering DA receptor expression. However, this possibility
remains to be investigated in detail.
Hand2
Hand2 (heart- and neural crest derivatives-expressed protein 2) is
a basic helix–loop–helix DNA binding protein that plays a role ine expression or function could lead to multiple ENS defects. At left a typical normal
Tþ dark blue, and GABAþ peach). Enteric glia normally reside within the ganglia,
hapes). Changes in neuron and glia numbers and imbalance of speciﬁc neuronal
uronal cell bodies) have already been described in some mouse mutants. These
of neurons and glia thus interfering with signaling between ENS components and
in GI dysfunction due to deﬁcits in motility and inappropriate immune response.
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recent years have implicated Hand2 in lineage divergence among
ENS progenitors (D’Autreaux et al., 2007, 2011; Hendershot et al.,
2007; Lei and Howard, 2011). Collectively, these efforts demonstrate
how loss of a single gene can alter proportions of speciﬁc neuronal
classes in the ENS with a signiﬁcant impact on intestinal motility.
Initially, Hendershot et al. (2007) ablated Hand2 expression in
NC derivatives through crosses of a conditional ﬂoxed allele
(Hand2tm1.1MajH:Wnt1-Cre) with a Wnt1 promoter driven-Cre trans-
gene (Danielian et al., 1997). This strategic approach removed
Hand2 from all NCC with the result that organization and con-
nectivity of enteric ganglia was disturbed accompanied by an
overall reduction in neuron numbers. Complete absence of VIP
expressing neurons from the fetal intestines of these mutants,
while ChATþ neurons were maintained, was the ﬁrst indication
that loss of Hand2 could have a speciﬁc effect on a discrete neuron
lineage. Subsequent analyses by Lei et al. (2011) depleted Hand2
from a speciﬁc subset of progenitors during ENS development
using a Nestin-Cre driver (allele Hand2tm1.1MajH:Nestin-Cre). Through
this reﬁned ablation of Hand2, a Nestin-independent population of
ENPs that accounted for approximately 15% of total neural pre-
cursors was revealed. In Hand2 depleted mutants, this population
was able to proliferate and compensate for a decrease in nestin-
dependent neurons. However, this compensatory effect was unique
to speciﬁc subsets of neurons in Hand2 mutants. For example,
Nestin-independent precursors were able to proliferate and com-
pensate for the loss in nestin-dependent ChAT neurons, but could
not compensate for the loss of NOS or calretinin expressing
neurons. Additionally, Nestin-independent precursors appeared
skewed towards a neuronal fate. In wild-type animals and
Nestin-driven Hand2 depleted mice, greater than 90% of glia were
Nestin-dependent. Glia were reduced overall in Nestin-driven
Hand2 depleted animals and nestin-independent precursors did
not compensate for this loss of glia. In addition to skewed ratios of
NC derivatives, nestin-driven Hand2 depleted mice had an overall
disorganized plexus and typically died by postnatal day 20. While
the cause of death was uncertain, these animals exhibited massive
distension of the entire GI tract, and it is certainly plausible that GI
dysfunction contributed to their premature death.
D’Autreaux et al. (2007) also observed that NC-speciﬁc depletion
of Hand2 disrupted terminal differentiation of enteric neurons. More-
over, this group later demonstrated that Hand2 depletion in the ENS
impacted not only GI motility, but inﬂammation as well (D’Autreaux
et al., 2011). They too noted disruption of enteric plexus organization
as well as a signiﬁcant decrease in NOS expressing neurons in Hand2
deﬁcient mice (Hand2þ / and Hand2ﬂox/), but they also found that
neuronal subtype speciﬁcation is Hand2 dosage speciﬁc by analyzing
ratios of NOSþ neurons in various combinations of Hand2 targeted
alleles. In contrast to the Lei et al. (2011) study, D’Autreaux et al.
(2011), found glia numbers were not signiﬁcantly reduced in the
myenteric plexus of Hand2 haplo-insufﬁcient mutants. This ﬁnding
could either reﬂect the capacity of enteric glia to differentiate despite
low levels of Hand2, temporal effects of Hand2, and/or the effect of
differential Hand2 expression levels in distinct NCC subpopulations.
Effects of transcription factor levels and timing have previously been
shown to play a role in cell lineage segregation in the pancreas
(Collombat et al., 2003; Hang and Stein, 2011; Liu et al., 2011; Pan
and Wright, 2011). And, differential expression transcription factor
levels may be functional in the ENS as well since this has been
documented in ENPs at stages concurrent with lineage segregation
(Corpening et al., 2008). Regardless of the underlying mechanism, the
D’Autreaux and Lei studies differ since Nestin-Hand2 depleted
mutants die near weaning with gross bowel distention, but
Hand2þ / mice are fertile and have a normal lifespan. However,
Hand2þ / heterozygotes do not have normal intestinal function, as
D’Autreaux et al. (2011) documented thesemutants have a signiﬁcantincrease in total GI transit time and markedly slower colonic motility
compared to wild-type littermates. Surprisingly, despite a reduction
in overall neuronal density and decrease in GI motility, Hand2þ /
mice are protected against TNBS induced inﬂammation when com-
pared to wild-type littermates (Margolis et al., 2011). This ﬁnding was
unexpected as increased gut motility is thought to protect against
microbial overgrowth and infection (Powell, 1995). Margolis et al.
(2011) concluded that an overall decrease in neuronal density is
protective against GI inﬂammation despite the decrease in moti-
lity seen in these mutants. Indeed, neurons have been implicated
in GI inﬂammation (Lakhan and Kirchgessner, 2010). However, it
is not yet known which enteric neuron subtypes contribute to
inﬂammatory processes, and future studies elucidating roles
for distinct neuronal subtypes and enteric glia in initiating and
propagating inﬂammation will be essential to understanding how
the ENS mediates enterocolitis.
Bone morphogenic proteins (BMPs)
BMPs orchestrate several developmental programs in a dosage
and time speciﬁc manner during the course of development
including neurogenesis in the developing gut. ENPs encounter
BMP signaling throughout development as the notochord and
somite mature (Faure et al., 2002). In addition, it is known that
BMP 2, 4, and 7 are expressed in the developing fetal intestine
(Chalazonitis et al., 2004, 2008).
The inﬂuence of BMPs agonists and antagonists on ENP lineage
segregation has been studied in vitro and in vivo for multiple
enteric lineages. In vitro, isolated rat ENPs treated with BMP2 and
BMP4 levels above those normally encountered in vivo appear to
specify TrkC expressing neurons prematurely and cause an overall
increase the number of TrkC expressing neurons (Chalazonitis
et al., 2004). Mouse models with neuronal BMP4 overexpression
show no changes in ENS neuronal density in vivo; however,
neuronal subtype proportions are skewed with signiﬁcant
increases in dopaminergic neurons, serotonergic neurons, and
TrkC expressing neurons in speciﬁc gut regions (Chalazonitis
et al., 2008). Additionally, BMP4 overexpression causes glial
numbers to increase markedly at the expense of neurons
(Chalazonitis et al., 2011).
Antagonism of BMP signaling in neurons through NSE-driven
noggin overexpression corroborated ﬁndings in regard to BMPs
role in ENS development. Noggin overexpression in neurons
increases overall ENS neuronal density which is consistent with
BMPs’ opposing role in promoting neural differentiation at the
expense of proliferation (Chen and Panchision, 2007). Noggin
overexpression increased the proportion of serotonergic neurons
(Chalazonitis et al., 2008), but led to decreases in TrkC and GABA
and CGRP expressing neurons (Chalazonitis et al., 2004, 2008) as
well as the glia to neuron ratio (Chalazonitis et al., 2011).
Importantly, these mice also exhibited irregular bowel transit
(Chalazonitis et al., 2008) as well as increased sensitivity to
chemically induced inﬂammation (Margolis et al., 2011). It is
clear that decreased BMP signaling tips the balance to favor more
neurons as well as certain neuronal subtypes; however, we can
only speculate now as to how these imbalances are exactly
inﬂuencing GI function. Also, it is imperative to mention that
these studies (Chalazonitis et al., 2004, 2008, 2011) and others
(Chen and Panchision, 2007) note the dosage and timing of BMP
expression affects the timing and differentiation capacity of
cell types.
Norepinephrine transporter (NET)
Although the ENS is not known to house any intrinsic norepin-
ephrine producing neurons, developing transiently catecholaminergic
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ently catecholaminergic subtypes include, but are not limited to, 5-HT
expressing neurons and some (but not all) Calretinin and NOS
expressing subtypes (Blaugrund et al., 1996; Li et al., 2010). To
determine if NET is essential for the speciﬁcation of these transiently
catecholaminergic neuronal subtypes, Li et al., (2010) evaluated
transiently catecholaminergic subtypes in the myenteric plexus of
NET null mice (Slc6a2tm1Mca common name NET /). NET / mice
have an overall decrease in myenteric neuron numbers, with 5-HT
and Calretininþ subsets signiﬁcantly reduced in number. In NET /
mutants, NOSþ neurons were observed to be slightly reduced in
number, but the reduction was not signiﬁcant. These results indicate
that NET is essential for certain transiently catecholaminergic sub-
types. However, it is unknown whether both the transiently catecho-
laminergic NOS and non-transiently catecholaminergic NOS
populations of neurons were largely unaffected by the NET deﬁciency
or if one of these populations was able to proliferate and compensate
for an undocumented loss in the other population.
Fgf2 and Sprouty2
Mutations in Sprouty2, an FGF2 antagonist, have been asso-
ciated with intestinal neuronal dysplasia (IND) in humans
(Borghini et al., 2009) and Fgf-2 / (Fgf2tm1Zllr/tm1Zllr) mice simi-
larly exhibit abnormally large ganglia that contain fewer, but
larger, neurons than wild-type mice (Hagl et al., 2008). Hagl et al.,
(2012) classiﬁed enteric neurons in Fgf-2 / mice based on
morphology (Hanani and Reichenbach, 1994) and found a sig-
niﬁcant decrease in calbindin expressing Dogiel Type 2 neurons.
Neurons may be classiﬁed by their shape, function, neurotrans-
mitters, electrical properties, and/or gene expression patterns.
Most of the studies mentioned previously used gene expression
detected by immunohistochemistry to classify neurons. Because
the studies by Hagl et al. (2012) assessed morphology and
calbindin expression as characteristic features, the authors
hypothesized that the neuronal population lost was sensory in
nature. Additionally, Fgf-2 / mice exhibit alterations in chloride
secretion and translocation of bacteria across the mucosal barrier.
How the ENS modulates permeability to bacterial penetration has
not been determined (Hagl et al., 2008).
Transgenic models
Recent development of ﬂuorescent transgenic mouse models
(Corpening et al., 2008; Druckenbrod and Epstein, 2005; Enomoto
et al., 2001) has permitted reﬁned analysis of ENS development
that were not previously possible by immunohistochemical stu-
dies of mutant strains. In particular, it has long been accepted that
ENPs either enter the foregut mesenchyme proximally and
migrate down its length in a rostral to caudal fashion (vagal
ENPs) or they enter the gut at the distal end and migrate caudal to
rostral (sacral ENPs). These processes left unexplained how
subsets of HSCR patients exhibit ’skip segment’ aganglionosis
where small region(s) of the colon contain ganglia (O’Donnell and
Puri, 2010) instead of continuous aganglionosis that is typically
seen in the distal colon. How skip segment aganglionosis might
arise given known mechanisms remained a quandary although
several groups suggested that extramural ENPs could account for
the ganglionated ’skip segments’ seen in some HSCR cases
(Coventry et al., 1994; O’Donnell and Puri, 2010). Synthesis of
information from multiple transgenic models now suggests that
these skip regions occur because normal migration of ENPs across
the mesentery between the small intestine and the colon occurs,
but subsequent ﬁlling of the proximal colon by ENPs that migrate
from the cecum fails. Mesenteric ENPs were initially reported by
Druckenbrod and Epstein, (2005). However, only recently hasmechanistic data emerged that can explain the role of these
mesenteric ENPs in skip segment aganglionosis. Recent analysis
using elegant live cell imaging has unequivocally shown that
ENPs migrate across gut mesentery to populate the majority of
the colon before cells migrating down the length of the gut tube
arrive (Nishiyama et al., 2012). The integration of these analyses
is just one more example of how studying fundamental processes
in normal development can serve to elaborate the etiology of
disease.Finding balance in the ENS
Post-surgery, chronic constipation and/or enterocolitis afﬂicts
many HSCR patients, and some Ednrb mouse models suffer from
enterocolitis as well despite surgical removal of the aganglionic
segment (Zhao et al., 2010). Because the distal aganglionic region
has been removed in these patients and mouse models, the effect
of and role played by ganglionated proximal intestine in long-
term GI function has to be considered. To date, evidence from two
distinct sources both suggest the balance of cell types within
enteric ganglia that derive from NC during lineage segregation
can signiﬁcantly alter the ENS. Studies from mouse models that
mimic the diagnostic feature of HSCR, aganglionosis, are in their
infancy, but initial data is consistent with the possibility of
disrupted lineage segregation in some mutants. Likewise analysis
of enteric development in mouse mutants that do not exhibit
overt aganglionosis (non-HSCR) also indicates that any one of
several gene deﬁcits can disrupt the normal processes of ENS
ontogeny and skew the resulting proﬁle of neurons and glia away
from normal composites. It should be emphasized that while
several non-HSCR mouse mutants exhibit alterations in enteric
neural crest lineages, how these imbalances directly or indirectly
cause GI dysfunction remains to be determined. Many studies
evaluating ENS architecture and composition do not assess GI
function and those preliminary studies that do understandably
focus on gross assessments, such as overall changes in GI transit
time or colonic motility. A need for further histological, physio-
logical, and electrophysiological studies to determine exactly how
certain populations and imbalances in these populations affect GI
function would be valuable for better understanding the etiology
of intestinal dysmotility.
As the ENS ﬁeld moves forward, we must consider several
factors. How much does one have to tilt the balance of neural
crest derivatives for GI dysmotility to occur? The answer to this
question is paramount. Some variability must exist for normal
bowel function to occur as inbred mice strains have different
proportions of neuronal subtypes (Neal et al., 2009), yet still
exhibit normal bowel function. It may be that only certain
environmental stressors, such as infection, cause certain imbal-
ances to manifest as disease. Reduced penetrance seen in some
human diseases could be due to a slight tip of the balance by
genetic modiﬁers, causing the balance to wax and wane between
disease and unaffected amongst family members. Other func-
tional bowel disorders in humans appear to have a genetic
component, but the genetic etiologies and risk factors remain
unknown. Small perturbations that do not lead to overt aganglio-
nosis, but cause imbalances of cell types within the ENS, could
explain disorders such as chronic constipation despite the pre-
sence of detectable enteric ganglia throughout the intestine as
well as residual deﬁcits seen in HSCR patients that suffer GI
dysfunction long after surgical intervention.
Additionally, recent studies have unearthed previously unrec-
ognized ENP subpopulations that appear to be distinct in their
developmental capacity. It was formerly believed that ENPs were
homogenous with regards to expression of Nestin, but Lei et al.
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population. A study by Mundell and colleagues (2012) revealed a
distinct ENP population that does not express Ednrb and appears
to have substantial capacity to compensate for loss of other
enteric progenitors during ENS development. The ability to fate-
map, isolate, and manipulate these and other subpopulations as
the ENS forms will be important. In the future, such efforts will
provide insight into how and when subpopulations are speciﬁed,
how distinct subpopulations inﬂuence lineage diversiﬁcation, and
deﬁne the ability of distinct subpopulations to compensate for
disturbances in other enteric cell types that might otherwise
derail GI motility and immune response.Acknowledgments
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